Illustrative new site acquisition spend
Company: Core Scientific
The claim, verbatim
Core Scientific's illustrative uses of the ~$2.9B net proceeds include $700–900M for new site acquisitions, leaving ~$2.0–2.2B of development equity.
Source (primary)
First Quarter Fiscal Year 2026 Earnings Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “New Site Acquisitions: ($700–900M) Remaining Development Equity: ~$2.0–2.2B”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms First Quarter Fiscal Year 2026 Earnings Presentation
Quote: “New Site Acquisitions: ($700–900M) Remaining Development Equity: ~$2.0–2.2B”